3 active not recruiting, 2 completed. 2 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Active not recruiting 1 |
Follow Allogeneic Hematopoietic Stem Cell Transplant Recipient: new trials by email Literature Review of Allogeneic Hematopoietic Stem Cell Transplant Recipient trials Research Report on Allogeneic Hematopoietic Stem Cell Transplant Recipient
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Etoposide - Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Active not recruiting | City of Hope Medical Center | 52 | 2021-04-30 | 2026-07-13 |
| Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant Biospecimen Collection-Blood, Biospecimen Collection-Stool - Allogeneic Hematopoietic Stem Cell Transplant Recipient, Donor | Active not recruiting | City of Hope Medical Center | 72 | 2018-11-13 | 2026-07-28 | |
| Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant Recombinant Human Papillomavirus Nonavalent Vaccine - Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm | Phase 4 | Active not recruiting | M.D. Anderson Cancer Center | 48 | 2017-04-23 | 2026-07-16 |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Fludarabine Phosphate - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia | Phase 2 | Completed | Fred Hutchinson Cancer Center | 84 | 2015-03-23 | 2026-06-01 |
| Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant Ipilimumab, Laboratory Biomarker Analysis, Nivolumab - Allogeneic Hematopoietic Stem Cell Transplant Recipient, Myeloproliferative Neoplasm | Phase 1 | Completed | National Cancer Institute (NCI) | 71 | 2013-05-16 | 2021-06-24 |
Hematologic Neoplasms (3) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myeloid, Acute (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Refractory, with Excess of Blasts (1) · Blast Crisis (1) · Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · Hodgkin Disease (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Accelerated Phase (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Bone Marrow Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Leukemia, Myeloid (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoproliferative Disorders (2)
Cyclophosphamide (2) · Tacrolimus (2) · CTLA-4 Antigen (1) · Etoposide (1) · Fibroblast Growth Factor 7 (1) · Human Papillomavirus Recombinant Vaccine nonavalent (1) · Ipilimumab (1) · Methotrexate (1) · Mycophenolic Acid (1) · Nivolumab (1) · Peripheral Blood Stem Cell Transplantation (1) · Sirolimus (1) · Thiotepa (1) · Whole-Body Irradiation (1) · fludarabine phosphate (1)
City of Hope Medical Center (2) · Fred Hutchinson Cancer Center (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1)
United States (5)
Jeannine S McCune (1) · Jessica P Hwang (1) · Karamjeet S Sandhu (1) · Marie Bleakley (1) · Matthew S Davids (1)
PMID 27410923, PMID 32478814, PMID 33720354, PMID 35007144
P01CA018029 (1), P30CA006516 (1), R01CA183559 (1), R01HL121568 (1), U01CA062490 (1), U01CA239373 (1), UM1CA186709 (1)